{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:32:38Z","timestamp":1792099958583,"version":"4.4.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The clinical manifestations of diabetic nephropathy are similar in type 1 and type 2 diabetes, while the renal lesions may differ. Indeed, diabetic glomerulopathy is the predominant renal lesion in type 1 diabetes, although also tubular, interstitial and arteriolar lesions are present in the advanced stages of renal disease. In contrast, in type 2 diabetes renal lesions are heterogeneous, and a substantial number of type 2 diabetic patients with diabetic kidney disease have mild or absent glomerulopathy with tubulointerstitial and\/or arteriolar abnormalities. In addition, a high prevalence of non-diabetic renal diseases, isolated or superimposed on classic diabetic nephropathy lesions have been reported in patients with type 2 diabetes, often reflecting the bias of selecting patients for unusual clinical presentations for renal biopsy. This review focuses on renal structural changes in type 2 diabetes, emphasizing the contribution of research kidney biopsy studies to the understanding of the pathogenesis of DKD and of the structural lesions responsible for the different clinical phenotypes. Also, kidney biopsies could provide relevant information in terms of renal prognosis, and help to understand the different responses to different therapies, especially SGLT2 inhibitors, thus allowing personalized medicine.<\/jats:p>","DOI":"10.1007\/s40620-020-00797-y","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T13:02:42Z","timestamp":1594558962000},"page":"901-907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Renal structure in type 2 diabetes: facts and misconceptions"],"prefix":"10.1093","volume":"33","author":[{"given":"Angelo","family":"Di Vincenzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mazzocut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3445-0387","authenticated-orcid":false,"given":"Paola","family":"Fioretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,12]]},"reference":[{"key":"797_CR1","unstructured":"https:\/\/www.usrds.org\/2019\/view\/USRDS_2019_ES_final.pdf"},{"key":"797_CR2","unstructured":"https:\/\/www.era-edta-reg.org\/files\/annualreports\/pdf\/AnnRep2016.pdf."},{"key":"797_CR3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00592-018-1142-y","volume":"55","author":"CB Giorda","year":"2018","unstructured":"Giorda CB, Carna P, Salomone M et al (2018) Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes. Acta Diabetol 55:733\u2013740","journal-title":"Acta Diabetol"},{"key":"797_CR4","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M et al (2010) Association of estimatef glomerular filtration rate and albuminuria and all-cause and cardiovascular mortality in genetral population cohorts: a collaborative meta-analysis. Lancet 375:2073\u201320181","journal-title":"Lancet"},{"key":"797_CR5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/ajkd.2002.31988","volume":"39","author":"G Mazzucco","year":"2002","unstructured":"Mazzucco G, Bertani T, Fortunato M et al (2002) Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. AJKD 39:713\u2013720","journal-title":"AJKD"},{"issue":"24","key":"797_CR6","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Petkovic","year":"2019","unstructured":"Petkovic V, Jardine MJ, Neal B et al (2019) Canagliflozin and renal outcomes in Type 2 diabetes and nephropathy. N Engl J Med 380(24):2295\u20132306","journal-title":"N Engl J Med"},{"key":"797_CR7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","volume":"7","author":"BL Neuen","year":"2019","unstructured":"Neuen BL, Young T, Heerspink HJL et al (2019) SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 7:845\u2013854","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"797_CR8","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2337\/diabetes.51.5.1580","volume":"51","author":"K Drummond","year":"2002","unstructured":"Drummond K, Mauer M (2002) The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 51(5):1580\u20131587","journal-title":"Diabetes"},{"issue":"4","key":"797_CR9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert TW, Mooyaart AL, Amann K et al (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21(4):556\u2013563","journal-title":"J Am Soc Nephrol"},{"key":"797_CR10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrneph.2010.96","volume":"6","author":"P Fioretto","year":"2010","unstructured":"Fioretto P, Mauer M (2010) Diabetic Nephropathy: challenges in pathologic classification. Nat Rev Nephrol 6:508\u2013510","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"797_CR11","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s001250050616","volume":"39","author":"P Fioretto","year":"1996","unstructured":"Fioretto P, Mauer M, Brocco E et al (1996) Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39(12):1569\u20131576","journal-title":"Diabetologia"},{"key":"797_CR12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00125-008-1051-7","volume":"51","author":"P Fioretto","year":"2008","unstructured":"Fioretto P, Caramori ML, Mauer M (2008) The kidney in diabetes: dynamic pathways of injury and repair. Diabetologia 51:1347\u20131355","journal-title":"Diabetologia"},{"issue":"2","key":"797_CR13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF01235631","volume":"8","author":"R Osterby","year":"1972","unstructured":"Osterby R (1972) Morphometric studies of the peripheral glomerular basement membrane in early juvenile diabetes. I. Development of initial basement membrane thickening. Diabetologia 8(2):84\u201392","journal-title":"Diabetologia"},{"issue":"4","key":"797_CR14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI111523","volume":"74","author":"SM Mauer","year":"1984","unstructured":"Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74(4):1143\u20131155","journal-title":"J Clin Invest"},{"key":"797_CR15","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2337\/diabetes.52.7.1818","volume":"52","author":"KN Drummond","year":"2003","unstructured":"Drummond KN, Kramer MS, Suissa S et al (2003) Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes 52:1818\u20131824","journal-title":"Diabetes"},{"key":"797_CR16","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/ndt\/gfu279","volume":"30","author":"M Mauer","year":"2015","unstructured":"Mauer M, Caramori ML, Fioretto P, Najafian B (2015) Glomerular structural-functional relationship models of diabetic nephropathy are robust in type 1 diabetic patients. Nephrol Dial Transplant 30:918\u2013923","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"797_CR17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ki.1991.187","volume":"40","author":"RD Harris","year":"1991","unstructured":"Harris RD, Steffes MW, Bilous RW, Sutherland DE, Mauer SM (1991) Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 40(1):107\u2013114","journal-title":"Kidney Int"},{"key":"797_CR18","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1681\/ASN.2005121342","volume":"17","author":"B Najafian","year":"2006","unstructured":"Najafian B, Crosson JT, Kim Y, Mauer M (2006) Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes. J Am Soc Nephrol 17:S53\u201360","journal-title":"J Am Soc Nephrol"},{"key":"797_CR19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1993.95","volume":"43","author":"PH Lane","year":"1992","unstructured":"Lane PH, Steffes MW, Fioretto P, Mauer M (1992) Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 43:661\u2013667","journal-title":"Kidney Int"},{"issue":"11","key":"797_CR20","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2337\/diab.43.11.1358","volume":"43","author":"P Fioretto","year":"1994","unstructured":"Fioretto P, Steffes MW, Mauer M (1994) Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43(11):1358\u20131364","journal-title":"Diabetes"},{"issue":"4","key":"797_CR21","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diabetes.52.4.1036","volume":"2","author":"ML Caramori","year":"2003","unstructured":"Caramori ML, Fioretto P, Mauer M (2003) Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes 2(4):1036\u20131040","journal-title":"Diabetes"},{"issue":"1","key":"797_CR22","doi-asserted-by":"publisher","first-page":"e000029","DOI":"10.1136\/bmjdrc-2014-000029","volume":"2","author":"T Moriya","year":"2014","unstructured":"Moriya T, Suzuki Y, Inomata S, Iwano M, Kanauchi M, Haneda M (2014) Renal histological heterogeneity and functional progress in normoalbuminuric and microalbuminuric Japanese patients with type 2 diabetes. BMJ Open Diabetes Res Care 2(1):e000029. https:\/\/doi.org\/10.1136\/bmjdrc-2014-000029","journal-title":"BMJ Open Diabetes Res Care"},{"key":"797_CR23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.1992.117","volume":"41","author":"H Hayashi","year":"1992","unstructured":"Hayashi H, Karasawa R, Inn H et al (1992) An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int 41:749\u2013757","journal-title":"Kidney Int"},{"key":"797_CR24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000058407","volume":"91","author":"T Moriya","year":"2002","unstructured":"Moriya T, Moriya R, Yajima Y, Steffes MW, Mauer M (2002) Urinary albumin excretion as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron 91:292\u2013299","journal-title":"Nephron"},{"key":"797_CR25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1172\/JCI119163","volume":"99","author":"ME Pagtalunan","year":"1997","unstructured":"Pagtalunan ME, Miller PL, Jumping-Eagle S et al (1997) Podocyte loss and progressive glomerular injury in type 2 diabetes. J Clin Invest 99:342\u2013348","journal-title":"J Clin Invest"},{"key":"797_CR26","first-page":"679A","volume":"16","author":"B Najafian","year":"2005","unstructured":"Najafian B, Caramori ML, Mauer M et al (2005) Clustering of type 1 and type 2 diabetic patients based on diabetic nephropathy structural-functional relationships. J Am Soc Nephrol 16:679A (abstr)","journal-title":"J Am Soc Nephrol"},{"key":"797_CR27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/diabetes.49.3.476","volume":"49","author":"R Nosadini","year":"2000","unstructured":"Nosadini R, Velussi M, Brocco E et al (2000) Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 49:476\u2013484","journal-title":"Diabetes"},{"issue":"5","key":"797_CR28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jdiacomp.2019.02.002","volume":"33","author":"T Moriya","year":"2019","unstructured":"Moriya T, Yamagishi T, Matsubara M, Ouchi M (2019) Serial renal biopsies in normo- and microalbuminuric patients with type 2 diabetes demonstrate that loss of renal function is associated with a reduction in glomerular filtration surface secondary to mesangial expansion. J Diabetes Complicat 33(5):368\u2013373","journal-title":"J Diabetes Complicat"},{"issue":"6","key":"797_CR29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1681\/ASN.2018111166","volume":"30","author":"HC Looker","year":"2019","unstructured":"Looker HC, Mauer M, Saulnier PJ et al (2019) Changes in albuminuria but not GFR are associated with early changes in kidney structure in type 2 diabetes. J Am Soc Nephrol 30(6):1049\u20131059","journal-title":"J Am Soc Nephrol"},{"key":"797_CR30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2215\/CJN.05760515","volume":"11","author":"GD Fufaa","year":"2016","unstructured":"Fufaa GD, Weil EJ, Lemley KV et al (2016) Structural predictors of loss of renal function in American Indians with type 2 diabete. Clin J Am Soc Nephrol 11:254\u2013261","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"797_CR31","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s001250051447","volume":"42","author":"TW Meyer","year":"1999","unstructured":"Meyer TW, Bennett PH, Nelson RG (1999) Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42(11):1341\u20131344","journal-title":"Diabetologia"},{"issue":"4","key":"797_CR32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2337\/diabetes.52.4.1031","volume":"52","author":"M Dalla Vestra","year":"2003","unstructured":"Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P (2003) Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 52(4):1031\u20131035","journal-title":"Diabetes"},{"issue":"6","key":"797_CR33","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/ndt\/gfh129","volume":"19","author":"KE White","year":"2004","unstructured":"White KE, Bilous RW (2004) Diabiopsies Study Group. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 19(6):1437\u20131444","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"797_CR34","first-page":"97","volume":"32","author":"M Fiorentino","year":"2017","unstructured":"Fiorentino M, Bolignano D, Tesar V et al (2017) Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrol Dial Transplant 32(1):97\u2013110","journal-title":"Nephrol Dial Transplant"},{"key":"797_CR35","doi-asserted-by":"publisher","first-page":"e4522","DOI":"10.7717\/peerj.4522","volume":"6","author":"D Liu","year":"2018","unstructured":"Liu D, Huang T, Chen N et al (2018) The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients-a retrospective descriptive study. PeerJ 6:e4522. https:\/\/doi.org\/10.7717\/peerj.4522","journal-title":"PeerJ"},{"issue":"4","key":"797_CR36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3109\/0886022X.2015.1007804","volume":"37","author":"T Soleymanian","year":"2015","unstructured":"Soleymanian T, Hamid G, Arefi M et al (2015) Non-diabetic renal disease with or without diabetic nephropathy in type 2 diabetes: clinical predictors and outcome. Ren Fail 37(4):572\u2013575","journal-title":"Ren Fail"},{"issue":"1","key":"797_CR37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","volume":"63","author":"AI Adler","year":"2003","unstructured":"Adler AI, Stevens RJ, Manley SE et al (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom prospective diabetes study (UKPDS 64). Kidney Int 63(1):225\u2013232","journal-title":"Kidney Int"},{"issue":"27","key":"797_CR38","doi-asserted-by":"crossref","first-page":"e4007","DOI":"10.1097\/MD.0000000000004007","volume":"95","author":"S De Cosmo","year":"2016","unstructured":"De Cosmo S, Viazzi F, Pacilli A et al (2016) Predictors of chronic kidney disease in type 2 diabetes: a longitudinal study from the AMD Annals initiative [published correction appears in Medicine (Baltimore). Medicine (Baltimore) 95(27):e4007","journal-title":"Medicine (Baltimore)"},{"key":"797_CR39","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.2337\/dc12-2572","volume":"36","author":"EI Ekinci","year":"2013","unstructured":"Ekinci EI, Jerums G, Skene A et al (2013) Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care 36:3620\u20133626","journal-title":"Diabetes Care"},{"key":"797_CR40","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diabetes.52.4.1036","volume":"52","author":"ML Caramori","year":"2003","unstructured":"Caramori ML, Fioretto P, Mauer M (2003) Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes 52:1036\u20131040","journal-title":"Diabetes"},{"issue":"22","key":"797_CR41","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117\u20132128","journal-title":"N Engl J Med"},{"issue":"7","key":"797_CR42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW et al (2017) Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 377(7):644\u2013657","journal-title":"N Engl J Med"},{"key":"797_CR43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"S Wiviott","year":"2019","unstructured":"Wiviott S, Raz I, Bonaca MP et al (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 380:347\u2013357","journal-title":"N Engl J Med"},{"issue":"10","key":"797_CR44","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/dom.12936","volume":"19","author":"SI Petrykiv","year":"2017","unstructured":"Petrykiv SI, Laverman GD, de Zeeuw D, Heerspink HJL (2017) The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patients. Diabetes Obes Metab 19(10):1363\u20131370","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"797_CR45","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/dom.13579","volume":"21","author":"HJL Heerspink","year":"2019","unstructured":"Heerspink HJL, Sjostrom CD, Inzucchi SE et al (2019) Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers. Diabetes Obes Metab 21(3):720\u2013725","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"797_CR46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199807093390202","volume":"339","author":"P Fioretto","year":"1998","unstructured":"Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339(2):69\u201375","journal-title":"N Engl J Med"},{"key":"797_CR47","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0140-6736(93)92183-T","volume":"342","author":"P Fioretto","year":"1992","unstructured":"Fioretto P, Mauer M, Bilous RW, Goetz FC, Steffes MW, Sutherland DE, Steffes MW (1992) Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet 342:1193\u20131196","journal-title":"Lancet"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00797-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-020-00797-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00797-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:38Z","timestamp":1777564598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/33\/5\/901\/8328502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,12]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1007\/s40620-020-00797-y","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,12]]},"assertion":[{"value":"22 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article doesn\u2019t contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}